Seema Dawood: Acquired Platelet Dysfunction with Eosinophilia – Bleeding Despite Normal Platelet Count
Seema Dawood, Medical Laboratory Technologist at The Aga Khan University Hospital, shared a post on LinkedIn:
“Acquired Platelet Dysfunction with Eosinophilia (APDE)
Condition characterized by bleeding tendency due to abnormal Platelet function, despite having a normal or near-normal platelet count, occurring together with Eosinophilia (increased Eosinophils in the blood).
Key Features
Patients present with abnormal bleeding: purpura, epistaxis, gum bleeding, etc.
Platelet count is usually normal, but platelet function is impaired.
Eosinophilia is present, commonly associated with:
- Parasitic infections
- Allergic diseases
- Certain immune-mediated conditions
Pathophysiology
Eosinophils release toxic granule proteins (e.g., Major Basic Protein, Eosinophil Cationic Protein).
These substances interfere with platelet function (aggregation and adhesion).
Result: ineffective hemostasis despite normal platelet count.
Clinical Importance
- Patients may have bleeding tendency even though platelet count is normal.
- Reported frequently in regions with high prevalence of parasitic infections (e.g., Southeast Asia).
- Treatment focuses on managing the underlying cause of Eosinophilia (e.g., treating parasitic infections).
- Once eosinophil count decreases, platelet function usually improves.
Summary:
APDE is an acquired condition where platelet dysfunction occurs in association with Eosinophilia, leading to bleeding tendency despite normal platelet count.
It is often linked to parasitic infections or allergies and improves when Eosinophilia is treated.
APDE is the only disease in which Pale Platelets are found.
Therefore, before reporting Pale Platelets, it is important to consider other consistent findings such as marked eosinophilia and the presence of purpura in the patient.”

See more in the gallery.
Stay updated with Hemostasis Today.
-
Jun 27, 2026, 01:31Alessio De Rose: Addressing Micronutrient Deficiencies in the Era of GLP-1 Receptor Agonists
-
Jun 27, 2026, 01:21Michelle Sámano Sánchez: Exploring Vitamin C as an Adjunct Therapy for Anemia in Hemodialysis
-
Jun 27, 2026, 01:08Ana Raquel Gotine: The First Pragmatic Clinical Trial on MNPs and Childhood Anemia in Mozambique
-
Jun 27, 2026, 00:56Sherif Badawy: Reflecting on My Time with ASH CRTI
-
Jun 27, 2026, 00:48Zain Khalpey: Why High quality CPR is Only Part of Successful Cardiac Arrest Management
-
Jun 26, 2026, 22:31Wendy Dusenbury: The New Issue of the Stroke Clinician is Now Live
-
Jun 26, 2026, 20:42Ed Watson: When It Happens to You, Stroke Becomes Personal, Immediate, and Life-Changing
-
Jun 26, 2026, 19:45Nathan Connell: Transforming Surgical Care with Tranexamic Acid
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?